Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes

scientific article published on January 1982

Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P698PubMed publication ID6314570

P50authorMaria MasucciQ39683404
P2093author name stringE Klein
P2860cites workThe transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferonQ45805720
Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropostive adults as revealed by an in vitro restimulation methodQ45805845
Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell linesQ45826585
A permanent human cytotoxic T-cell line with high killing capacity against a lymphoblastoid B-cell line shows preference for HLA A, B target antigens and lacks spontaneous cytotoxic activityQ52225931
Establishment of cell lines from peripheral leucocytes in infectious mononucleosis.Q52834027
The role of gene dosage and genetic transpositions in carcinogenesisQ53569200
Effect of Immunization on the Spread of Transplanted Mouse Lymphoma Cells2Q54504989
Use of cryopreserved lymphocytes for the indirect leukocyte migration inhibition assayQ61788196
Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cellQ67415874
Disappearance of the NK effect after explantation of lymphocytes and generation of similar nonspecific cytotoxicity correlated to the level of blastogenesis in activated culturesQ70524148
Interferon production and activation of non-specific effector cells by stimulation with lymphoblastoid cell lines in vitroQ72647232
Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosisQ35077262
Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytesQ36335723
Target selectivity of interferon-induced human killer lymphocytes related to their Fc receptor expressionQ36394762
HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virusQ36398950
Tumorigenicity of human hematopoietic cell lines in athymic nude miceQ39140286
EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patientsQ39366390
Lymphocyte transformation induced by autologous cells. III. Lymphoblast-induced lymphocyte to stimulation does not correlate with EB viral antigen expression or immunityQ39366634
Lymphoblastoid Cell Lines are Polyclonal Activators of Human T LymphocytesQ39536179
Lymphocyte transformation induced by autologous cells. V. generation of immunologic memory and specificity during the autologous mixed lymphocyte reactionQ39835040
Cultivation with K562 cells leads to blastogenesis and increased cytotoxicity with changed properties of the active cells when compared to fresh lymphocytesQ39871271
Enhanced destruction of lymphoid cell lines by peripheral blood leukocytes taken from patients with acute infectious mononucleosisQ39943433
Human lymphoblastoid cell lines derived from individuals without lymphoproliferative disease contain the same latent forms of epstein-barr virus dna as those found in tumor cellsQ40091396
An immunological basis for inhibition of transformation of human lymphocytes by EB virusQ40093785
Variable Phenotypic Expression of an X-Linked Recessive Lymphoproliferative SyndromeQ40101109
Epstein-Barr-Virus Immunity and Tissue Distribution in a Fatal Case of Infectious MononucleosisQ40119435
Induction of ebna precedes the first cellular S-phase after ebv-infection of human lymphocytesQ40129192
Studies on cytotoxicity generated in human mixed lymphocyte cultures. I. Time course and target spectrum of several distinct concomitant cytotoxic activitiesQ40140874
Cell-density-dependence for growth in agarose of two human lymphoma lines and its decrease after epstein-barr virus conversionQ40198212
Characterization of thymus-derived lymphocyte subsets in acute Epstein-Barr virus-induced infectious mononucleosisQ40204672
Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte culturesQ40238404
Cells containing Epstein--Barr nuclear antigen (EBNA) in peripheral bloodQ40256472
Inhibition of the in vitro outgrowth of Epstein-Barr virus-infected lymphocytes by TG lymphocytesQ40260453
Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious MononucleosisQ40262031
EBV specific killer T cells and serologic responses after onset of infectious mononucleosisQ40268762
Characterization of cytotoxic human lymphocyte subpopulations: The role of Fc-receptor-carrying cellsQ40657154
Human spontaneous killer cells selective for tumour-derived target cellsQ40669355
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virusQ40850280
Activation of Lymphocytes from Epstein-Barr Virus-Seronegative Donors by Autologous Epstein-Barr Virus-Transformed CellsQ43684586
Cell-surface immunoglobulin and insulin receptor expression in an EBV-negative lymphoma cell line and its EBV-converted sublinesQ44064280
T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosisQ44658488
Lymphocyte Reactivity in Infectious MononucleosisQ44815388
Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigensQ45214821
Effect of different Epstein-Barr virus-determined antigens (EBNA, EA, and VCA) on the leukocyte migration of healthy donors and patients with infectious mononucleosis and certain immunodeficienciesQ45799773
Generationin vitro of HLA-restricted EB virus-specific cytotoxic human T cells by autologous lymphoblastoid cell lines: The roles of previous EB virus infection and foetal calf serumQ45800730
Studies on long-term T-cell-mediated immunity to epstein-barr virus in immunosuppressed renal allograft recipientsQ45800733
Cell-mediated immune reactions in three patients with malignant lymphoproliferative diseases in remission and abnormally high Epstein-Barr virus antibody titersQ45801124
Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridizationQ45801129
Long-term T-cell-mediated immunity to Epstein-Barr virusQ45801134
Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinantsQ45801240
Cytotoxic cells induced in vitro by Epstein-Barr Virus antigensQ45801579
Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformationQ45802007
Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein–Barr virus-induced B-cell linesQ45802718
In vitro induction of cytotoxic T lymphocytes specific for Epstein-Barr virus-transformed cells: kinetics of autologous restimulationQ45803877
The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cellQ45804001
Cellular immune defects to Epstein-Barr virus-determined antigens in young malesQ45805432
Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell lineQ45805481
P433issue1
P921main subjectEpstein–Barr virusQ6900
P304page(s)63-73
P577publication date1982-01-01
P1433published inSeminars in ImmunopathologyQ15724576
P1476titleCell-mediated immunity against Epstein-Barr virus infected B lymphocytes
P478volume5

Reverse relations

cites work (P2860)
Q45835799Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A.
Q44360993Impaired autologous mixed lymphocyte reaction (AMLR) in patients with ataxia-telangiectasia and their family members.

Search more.